OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The complexity of Alzheimer’s disease: an evolving puzzle
Camilla Ferrari, Sandro Sorbi
Physiological Reviews (2021) Vol. 101, Iss. 3, pp. 1047-1081
Closed Access | Times Cited: 207

Showing 26-50 of 207 citing articles:

Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies
Yuxun Wei, Hong Li, Yue Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7

Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer’s disease
Junqiu He, Kin Yip Tam
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103914-103914
Closed Access | Times Cited: 6

Neuroprotective effects of dipeptidyl peptidase 4 inhibitor on Alzheimer’s disease: a narrative review
Xin Jiang, Ji Li, Xiaohui Yao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6

β-Amyloid peptide modulates peripheral immune responses and neuroinflammation in rats
Krishnendu Adhikary, Satyajit Mohanty, Bidyut Bandyopadhyay, et al.
BioMolecular Concepts (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6

Understanding Alzheimer's Disease
Alexander R Strofs
Journal of Student Research (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6

Hybrid molecules based on caffeic acid as potential therapeutics: A focused review
Xue Zhi Zhao, Ziwei Liu, Hao Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114745-114745
Closed Access | Times Cited: 28

Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults
Kátia de Paiva Lopes, Lei Yu, Xianli Shen, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 525-537
Open Access | Times Cited: 15

The Role of Artificial Intelligence in Deciphering Diet–Disease Relationships: Case Studies
Yotam Cohen, Rafael Valdés‐Mas, Eran Elinav
Annual Review of Nutrition (2023) Vol. 43, Iss. 1, pp. 225-250
Open Access | Times Cited: 14

Construction and evaluation of Alzheimer’s disease diagnostic prediction model based on genes involved in mitophagy
Yongyan Pei, Sijia Chen, Fengling Zhou, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 13

Neurotrophic Natural Products
Yoshiyasu Fukuyama, Miwa Kubo, Kenichi Harada
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2024), pp. 1-473
Closed Access | Times Cited: 5

Inhibition of Alzheimer's disease by 4-octyl itaconate revealed by RNA-seq transcriptome analysis
Yingchao Liu, Pengcheng Xia, Shuai Zong, et al.
European Journal of Pharmacology (2024) Vol. 968, pp. 176432-176432
Closed Access | Times Cited: 5

Level of LncRNA GAS5 and Hippocampal Volume are Associated with the Progression of Alzheimer’s Disease
Xiaopeng Chen, Guoqiang Ren, Yan Li, et al.
Clinical Interventions in Aging (2022) Vol. Volume 17, pp. 745-753
Open Access | Times Cited: 20

Advancing Alzheimer’s Therapeutics: Exploring the Impact of Physical Exercise in Animal Models and Patients
Jesús Andrade-Guerrero, Paola Rodríguez-Arellano, Nayeli Barron-Leon, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2531-2531
Open Access | Times Cited: 12

Extracellular vesicles from hiPSC-NSCs can prevent peripheral inflammation-induced cognitive dysfunction with inflammasome inhibition and improved neurogenesis in the hippocampus
Gunel Ayyubova, Maheedhar Kodali, Raghavendra Upadhya, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 12

The Protective Effect of Mangiferin on Formaldehyde-Induced HT22 Cell Damage and Cognitive Impairment
Fan Chen, Na Wang, Xin-Yan Tian, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1568-1568
Open Access | Times Cited: 11

Polygala tenuifolia and Acorus tatarinowii in the treatment of Alzheimer’s disease: a systematic review and meta-analysis
Yuchen Zhang, Jinzhou Tian, Jingnian Ni, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4

A facile two-photon red-emission fluorescent marker with a large Stokes shift for in vivo brain imaging of amyloid-beta aggregates
Miao Chen, Ziwei Zhang, Zhen Shi, et al.
Cell Reports Physical Science (2024) Vol. 5, Iss. 2, pp. 101810-101810
Open Access | Times Cited: 4

Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect
Xinyi Wang, Li Chen, Weijian Li, et al.
Journal of Alzheimer s Disease (2025)
Closed Access

Metabolic Engineering of Escherichia coli for De Novo Biosynthesis of the Platform Chemical Pelletierine
Wei Li, Peng Zhao, Ying Li, et al.
ACS Sustainable Chemistry & Engineering (2025)
Closed Access

Novel donepezil-tacrine hybrid (TAHB3) induces neurodifferentiation, neuroprotective effects, and activates the PI3K/AKT pathway on PC12 cells
Renata Melo dos Santos Ono, Natália Moreira, Ivone Carvalho, et al.
Journal of Alzheimer s Disease Reports (2025) Vol. 9
Open Access

Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
Emma Ortiz, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 128-128
Open Access

Scroll to top